Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

94 results about "Systemic blood" patented technology

Systemic blood circulation is a part of cardiovascular system or circulatory system. Circulatory system is divided in two parts: systemic circulation and pulmonary circulation. In the former case, the purified blood from the heart is collected with the help of arteries and is supplied to different parts of the body.

Administration of anti-inflammatory drugs into the central nervous system

Apparatus is provided for delivering a Non Steroidal Anti-Inflammatory Drug (NSAID) supplied to a body of a subject for delivery to at least a portion of a central nervous system (CNS) of the subject via a systemic blood circulation of the subject, including a stimulator adapted to stimulate at least one site of the subject, so as to cause an increase in passage of the NSAID from the systemic blood circulation across a blood brain barrier (BBB) of the subject to the portion of the CNS, during at least a portion of the time that the NSAID is present in the blood, the site selected from the list consisting of: a sphenopalatine ganglion (SPG) of the subject, an anterior ethmoidal nerve of the subject, a posterior ethmoidal nerve of the subject, a communicating branch between an anterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a communicating branch between a posterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a greater palatine nerve of the subject, a lesser palatine nerve of the subject, a sphenopalatine nerve of the subject, a communicating branch between a maxillary nerve and an SPG of the subject, a nasopalatine nerve of the subject, a posterior nasal nerve of the subject, an infraorbital nerve of the subject, an otic ganglion of the subject, an afferent fiber going into the otic ganglion of the subject, an efferent fiber going out of the otic ganglion of the subject, a vidian nerve of the subject, a greater superficial petrosal nerve of the subject, and a lesser deep petrosal nerve of the subject.
Owner:BRAINSGATE LTD

Method for delivering a fluid to the coronary ostia

InactiveUS6913601B2Maintenance stopReduce in quantityGuide needlesStentsMinimally invasive cardiac surgeryCoronary artery ostium
A catheter system is provided for accessing the coronary ostia transluminally from a peripheral arterial access site, such as the femoral artery, and for inducing cardioplegic arrest by direct infusion of cardioplegic solution into the coronary arteries. In a first embodiment, the catheter system is in the form of a single perfusion catheter with multiple distal branches for engaging the coronary ostia. In a second embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single arterial cannula. In a third embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single guiding catheter. In a fourth embodiment, multiple catheters are delivered to the coronary ostia through a single guiding catheter which has distal exit ports that are arranged to direct the perfusion catheters into the coronary ostia. In each embodiment, the catheters are equipped with an occlusion means at the distal end of the catheter for closing the coronary ostia and isolating the coronary arteries from the systemic blood flow. The occlusion means can take the form of an inflatable occlusion balloon cuff, a tapered occlusion device or an O-ring encircling the distal end of the catheter. An optional ventricular venting catheter can be included in the system for venting blood and fluids from the left ventricle of the heart. The catheter system is combined with a femoral-to-femoral cardiopulmonary bypass system to provide a system for cardioplegic arrest and total cardiopulmonary support during minimally invasive cardiac surgical procedures.
Owner:EDWARDS LIFESCIENCES LLC

Method for treating diseases associated with changes of qualitative and/quantitative composition of blood extracellular dna

The invention relates to medicine and veterinary science and can be used for treating diseases associated with changes of the qualitative and/quantitative composition of blood extracellular DNA, namely generalised infection diseases provoked by bacteria, diseases provoked by fungi and protozoa, atherosclerosis, pancreatic diabetes, allergic diseases associated with delayed response hypersensitivity and diseases due to somatic cell gene mutations. The inventive method for treating diseases associated with modifications of the qualitative and/or quantitative composition of blood extracellular DNA, namely generalised infection diseases provoked by bacteria, diseases provoked by fungi and protozoa, atherosclerosis, pancreatic diabetes, allergic diseases associated with delayed response hypersensitivity and diseases due to somatic cell gene mutations consists in injecting an agent destroying blood extracellular DNA. DNAse enzyme injected into a systemic blood circulation in doses which modify the electrophoretic profile of the blood extracellular DNA definable by pulse-electrophoresis can be used in the form of an agent destroying said blood extracellular DNA. Said DNAse enzyme can be injected in doses and at regimes ensuring the level of a blood plasma DNA-hydrolytic activity which is measured in the blood plasma and is higher than 150 Kunz units per litre of plasma during a total time higher than 12 hours a day. The inventive method makes it possible to develop a high-efficient and low-toxic method for treating diseases associated with modifications of qualitative and/or quantitative composition of blood extracellular DNA individually or in combination thereof.
Owner:CLS THERAPEUTICS

Hot compress traditional Chinese medicinal composition for promoting rehabilitation of neck-shoulder and lumbocrural pain

InactiveCN105943642ARelax musclesDilated capillariesAntipyreticAnalgesicsDiseaseCutaneous telangiectasia
The invention discloses a hot compress traditional Chinese medicinal composition for promoting rehabilitation of neck-shoulder and lumbocrural pain. The composition consists of the following raw material components in parts by weight: 10-20g of radix saposhnikoviae, 10-30g of rhizoma cibotii, 10-20g of rhizoma seu radix notopterygii, 6-10g of herba ephedra, 8-15g of rhizoma ligustici wallichii, 10-15g of cassia twig, 10-20g of radix clematidis, 6-10g of radix glycyrrhizae preparata, 10-20g of flos carthami, 10-20g of radix angelicae sinensis and 10-20g of eucommia bark. In accordance with diseases, the medicinal components of the weights are crushed and are soaked in a mixed solution of Baijiu which is at 50 degrees in alcoholic strength and rice vinegar in a mode of being packaged in a gauze bag, after 2 days, the medicine bag (the gauze bag) is taken out, liquid in the bag is squeezed out with hands and the medicine bag is steamed in a pot, the medicine bag is taken out after being boiled in the pot for 10min, the medicine bag is cooled and is covered by a preservative film, and then the hot water bag is applied to the medicine bag for 30-60min per time. The traditional Chinese medicine disclosed by the invention, through hot compress, can be used for effectively relaxing muscles and dilating skin capillaries, so that local blood circulation and systemic blood circulation are subsequently improved; and the traditional Chinese medicinal composition has a good effect on various inflammatory responses and painful diseases.
Owner:雷世昌

Limb local drug delivery and dialysis device and application thereof

ActiveCN104307064APurpose of treating localized diseaseLimited blood circulationSemi-permeable membranesDialysis systemsWhole bodyVenous blood
The invention discloses a limb local drug delivery and dialysis device and an application thereof. The limb local drug delivery and dialysis device is characterized in that an arterial blood inlet, an arterial blood outlet and at least one drug delivery inlet are arranged on an arterial chamber, wherein the arterial blood inlet is matched with one end of a main artery, and the arterial blood outlet is matched with the other end of the main artery. A venous blood inlet, a venous blood outlet, a dialysate inlet and a dialysate outlet are arranged on a venous chamber, wherein the venous blood inlet is matched with the limb side of the vein, and the venous blood outlet is matched with the proximal side of the vein. A blood coil of a dialysing tube structure is arranged in the venous chamber, one end of the blood coil is connected with the venous blood inlet, and the other end of the blood coil is connected with the venous blood outlet. The limb local drug delivery and dialysis device filter backflow venous blood molecules with specific sizes while performing arterial drug delivery, provides drugs for limbs on the affected side, and limits the drugs to the blood circulation in the affected limbs; discharges harmful substances generated by the affected limbs and prevents the harmful substances from entering whole-body blood circulation, thereby achieving the purpose of treating localized lesions of the limbs.
Owner:SHANGHAI SIXTH PEOPLES HOSPITAL

In-vivo closed-loop extraction device for circulating tumor cells (CTC)

The invention discloses an in-vivo closed-loop extraction device for circulating tumor cells (CTC). The device comprises a blood collection unit, wherein the blood collection unit is connected with aprimary separation unit through a first blood transfusion tube; the primary separation unit is connected with a fine separation unit or a storage unit through a second blood transfusion tube; the primary separation unit is further connected with a reverse-transfusion unit through a third blood transfusion tube; the primary separation unit is used for separating blood into components containing thecirculating tumor cells and components containing no circulating tumor cells; the fine separation unit is connected with the reverse-transfusion unit through a fourth blood transfusion tube; the fineseparation unit is further connected with the storage unit through a discharge pipe; the fine separation unit is used for extracting the circulating tumor cells from the components containing the circulating tumor cells; the storage unit is used for storing the components containing the circulating tumor cells and/or the circulating tumor cells; a control unit is separately connected with the blood collection unit, the primary separation unit, the fine separation unit, and the reverse-transfusion unit. The device disclosed by the invention has one beneficial effect that the circulating tumorcells in the whole body can be removed by filtration.
Owner:刘忠英

Metformin anti-aging skin care product

The invention provides a metformin anti-aging skin care product, which comprises metformin, other active ingredients, conventional raw materials, auxiliary materials and the like, and can be preparedinto paste, emulsion, cream, a gel, spray, milk, lotion and other forms through dissolving, heating, stirring, cooling and other process methods. According to the invention, the anti-aging drug metformin and other active ingredients in the skin care product can directly act on the surface of skin, or permeate into local or whole-body blood circulation through skin so as to achieve the effect of transdermal drug delivery, and can be used for skin aging resistance, body aging resistance and treatment of various diseases such as type 2 diabetes mellitus, polycystic ovarian syndrome, tumors and other like; with the metformin anti-aging skin care product, the damage to the oral metformin medicine in the gastrointestinal tract, the possible first-pass effect of live and the gastrointestinal inactivation are avoided, the damage to liver and kidney is reduced, toxic and side effects are reduced, and a new method and way are provided for safely and effectively expanding the range of users; andthe anti-skin aging or anti-body aging and the medication method are simple, convenient, easy and acceptable.
Owner:程定超
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products